Ying Xiao

563 citations
30 papers · 417 indexed · h-index 12

Ying Xiao

29 papers receiving 406 citations

Peers

Ying Xiao
Comparison fields: 5 of 113
  • Toxicology 14
  • Cardiology and Cardiovascular Medicine 80
  • Insect Science 36
  • Pharmacology 39
  • Aging 4
Replace Jiro Kitamura with:
Jiro Kitamura Japan
Jianhui He China
Qian Shi China
Yun‐Hsin Wang Taiwan
Denhí Schnabel Mexico
Xuelin Chen China
Wenjie Cao China
Satish Asotra Canada
Sara Choi United States
Ying Xiao relative to Jiro Kitamura Japan Jiro Kitamura's profile →
Citations per field
00.5×12.2×
Jiro Kitamura · 1×
Citations per year

Countries citing papers authored by Ying Xiao

Since Specialization
Citations

This map shows the geographic impact of Ying Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Xiao more than expected).

Fields of papers citing papers by Ying Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Xiao. The network helps show where Ying Xiao may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ying Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ying Xiao Line = papers co-authored together Ying Xiao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 202336
3 202218
4 202226
5 202115
6 202017
7 20201
8 20205
9 20201
10 201878
11 201811
12 20184
13
Exploring the Feasibility of Video-Mediated Listening Test in a Nation-Wide Proficiency English Examination in China.
20171
14 201719
15 201734
16 20158
17 201443
18
[Effect of electroacupuncture stimulation of "Fenglong" (ST 40) on expression of inflammatory cytokines of celiac macrophages in hyperlipidemia rats].
20142
19 201337
20 20033

About Ying Xiao

Ying Xiao is a scholar working on Complementary and alternative medicine, Toxicology and Finance, having authored 30 papers that have together received 417 indexed citations. Recurring topics across this work include Corporate Finance and Governance (3 papers), Financial Markets and Investment Strategies (3 papers), Acupuncture Treatment Research Studies (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), Atrial Fibrillation Management and Outcomes (2 papers), Diet and metabolism studies (2 papers), Natural product bioactivities and synthesis (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Toxicology (14 citations), Cardiology and Cardiovascular Medicine (80 citations) and Insect Science (36 citations). Ying Xiao has collaborated with scholars based in China, United States and France. Frequent co-authors include Catherine Mignolet, Marc Benoît, Yuepeng Wang, Yi‐Gang Li, Shuai Song, Qunshan Wang, Wei Cao, Guojian Fang, Xin Zhao and Rui Zhang. Their work appears in journals such as The Journal of Experimental Medicine, British Journal of Pharmacology and Journal of Ethnopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026